InvestorsHub Logo
Followers 231
Posts 14706
Boards Moderated 1
Alias Born 03/29/2014

Re: flipper44 post# 98612

Friday, 01/27/2017 3:54:33 PM

Friday, January 27, 2017 3:54:33 PM

Post# of 703798

I noticed Dr. Schwartz emphasized how important it was to obtain post-progression images as well. If this is being used informally in the Phase III trial for image interpretation review, that could explain some delay.



Especially because I think everyone in the field are fast becoming aware that immunoncology treatments require an ever-evolving criteria assessment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News